Tyrosine Kinase Inhibitor

Ethan Craig, MD, spoke with Healio about treatment options coming up in the pipeline for psoriatic arthritis.

In this Healio Video Perspective from the Retina Society meeting, Sumit Sharma, MD, of Cole Eye Institute discusses how tyrosine kinase inhibitors differ from other treatment options for retinal diseases.

SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.

SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a study assessing the effects of tapering to withdraw of TNF inhibitors compared with stable use among patients with rheumatoid arthritis.

SAN DIEGO — Kathryn Dao, MD, discusses a study presented at ACR Convergence 2023 that compared the initiation of TNF inhibitors with non-TNF inhibitor biologics or JAK inhibitors among patients with rheumatoid arthritis-associated interstitial lung disease.

MADRID — In a video interview with Healio, Sumanta (Monty) Pal, MD, FASCO, spoke about the STELLAR-304 clinical trial for patients with non-clear cell renal cell carcinoma at ESMO Congress.

Healio spoke with Gwen Nichols, MD, to discuss survivorship in CML patients.

Healio spoke with Gwen Nichols, MD, to discuss how to approach CML treatment in pediatric patients.

Healio spoke with Gwen Nichols, MD, about treatment options currently available in CML.